The speculation is that this is the year.
San Francisco Telehealth Summit, February 11, 2021
You are here
Pear Therapeutics licenses voice biomarkers for dementia and psychiatric disorders
Fri, 01/10/2020 - 10:11 - Laurie Orlov
To improve treatment for patients with illnesses ranging from Alzheimer’s to insomnia and substance use disorder.
category tags:
Tuesday, January 7, 2020
Printer-friendly version